Checking the Overall Picture for Geron Corporation (GERN)

Geron Corporation (GERN) is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the tape, currently trading at $2.98, up from yesterday’s close by 1.71%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.

Fundamental Analysis

Geron Corporation (GERN) currently trades with a market capitalization of $474.47 Million. That value represents a market adjusting for revenues that have been falling by -96.81 % on a quarterly year/year basis as of the company’s last quarterly report.

You can get a sense of how sustainable that is by a levered free cash flow of -$16.17 Million over the past twelve months. Generally speaking, earnings are expected to hold steady in coming quarters. Analysts are forecasting earnings of -$0.05 on a per share basis this quarter. Perhaps, that suggests something about why 3.14% of the outstanding share supply is held by institutional investors.

Technical Analysis

We’ve taken a serious look at this stock from a fundamental perspective, but the tale of the tape may offer more hints about what lies under the surface. Looking at the stock’s movement on the chart, Geron Corporation recorded a 52-week high of $3.15. It is now trading 0.17% off that level. The stock is trading $2.25 its 50-day moving average by -0.73%. The stock carved out a 52-week low down at $1.74.

In recent action, Geron Corporation (GERN) has made a move of +35.45% over the past month, which has come on Strong relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 16.68, and it’s gotten there by action that has been more volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 22.42% with $158.38 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of GERN.

Previous articleConocoPhillips (COP): What’s the Story?
Next articleHow Does Edison International (EIX) Stack Up Right Now?